4th Quarter - Report

EMD MILLIPORE CORPORATION for EMD MILLIPORE CORPORATION

Firm
Client
Income
—
Expenses
$90,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Discussions related to concern about inclusion of biotechnology in potential rule to institute export controls or require screening of outbound investments

Foreign entity interest: Merck, KGaA, the Foreign Entity listed on the LD-1, has an interest in the matter noted in Section 16.

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: U.S. Trade Representative (USTR); Commerce, Dept of (DOC); White House Office

Health Issues HCR

Discussions related to the Pandemic response effort and the use of public-private partnerships with the Health and Human Services' Assistant Secretary for Preparedness and Responses' (ASPR) and the Biomedical Advanced Research and Development Authority (BARDA)

Foreign entity interest: Merck, KGaA, the Foreign Entity listed on the LD-1, has an interest in the matter noted in Section 16.

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Health & Human Services, Dept of (HHS)

Manufacturing MAN

Discussions related to support for federal incentives to re-shore manufacturing for the U.S. medical supply chain

Foreign entity interest: Merck, KGaA, the Foreign Entity listed on the LD-1, has an interest in the matter noted in Section 16.

LobbyistCovered position, as disclosed
ANDREW TANTILLO —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.